{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:39:42Z","timestamp":1780072782109,"version":"3.54.0"},"reference-count":237,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001516","name":"National Heart Foundation of New Zealand","doi-asserted-by":"publisher","award":["1600"],"award-info":[{"award-number":["1600"]}],"id":[{"id":"10.13039\/501100001516","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001563","name":"Otago Medical Research Foundation","doi-asserted-by":"publisher","award":["AG307"],"award-info":[{"award-number":["AG307"]}],"id":[{"id":"10.13039\/501100001563","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008247","name":"University of Otago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008247","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Otago Doctoral Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12933-016-0484-4","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T14:38:41Z","timestamp":1484318321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways"],"prefix":"10.1186","volume":"16","author":[{"given":"Jason Kar Sheng","family":"Lew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl O.","family":"Schwenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5419-7935","authenticated-orcid":false,"given":"Rajesh","family":"Katare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"key":"484_CR1","unstructured":"International diabetes federation: IDF DIABETES ATLAS Sixth edition. KEY FINDINGS 2014. http:\/\/www.idf.org\/diabetesatlas\/update-2014 . Accessed 4 Dec 2016."},{"key":"484_CR2","unstructured":"American Heart Association: Cardiovascular Disease & Diabetes. http:\/\/www.heart.org\/HEARTORG\/Conditions\/Diabetes\/WhyDiabetesMatters\/Cardiovascular-Disease-Diabetes_UCM_313865_Article.jsp\/-.ViN43CTlfFI . Accessed 4 Dec 2016."},{"issue":"2","key":"484_CR3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/cvr\/cvp017","volume":"82","author":"JJ Wright","year":"2009","unstructured":"Wright JJ, Kim J, Buchanan J, Boudina S, Sena S, Bakirtzi K, Ilkun O, Theobald HA, Cooksey RC, Kandror KV, et al. Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding. Cardiovasc Res. 2009;82(2):351\u201360.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"484_CR4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/eurheartj\/ehp396","volume":"31","author":"SA Cook","year":"2010","unstructured":"Cook SA, Varela-Carver A, Mongillo M, Kleinert C, Khan MT, Leccisotti L, Strickland N, Matsui T, Das S, Rosenzweig A, et al. Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. Eur Heart J. 2010;31(1):100\u201311.","journal-title":"Eur Heart J"},{"issue":"5","key":"484_CR5","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1172\/JCI40096","volume":"120","author":"I Shimizu","year":"2010","unstructured":"Shimizu I, Minamino T, Toko H, Okada S, Ikeda H, Yasuda N, Tateno K, Moriya J, Yokoyama M, Nojima A, et al. Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents. J Clin Investig. 2010;120(5):1506\u201314.","journal-title":"J Clin Investig"},{"issue":"1","key":"484_CR6","doi-asserted-by":"crossref","first-page":"H38","DOI":"10.1152\/ajpheart.01295.2005","volume":"291","author":"IC Okere","year":"2006","unstructured":"Okere IC, Chandler MP, McElfresh TA, Rennison JH, Sharov V, Sabbah HN, Tserng KY, Hoit BD, Ernsberger P, Young ME, et al. Differential effects of saturated and unsaturated fatty acid diets on cardiomyocyte apoptosis, adipose distribution, and serum leptin. Am J Physiol Heart Circ Physiol. 2006;291(1):H38\u201344.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"12","key":"484_CR7","doi-asserted-by":"crossref","first-page":"10297","DOI":"10.1074\/jbc.M212307200","volume":"278","author":"JA Chavez","year":"2003","unstructured":"Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT, Florant GL, Summers SA. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem. 2003;278(12):10297\u2013303.","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"484_CR8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1023\/A:1010899724222","volume":"220","author":"D Hagemann","year":"2001","unstructured":"Hagemann D, Bohlender J, Hoch B, Krause EG, Karczewski P. Expression of Ca2+\/calmodulin-dependent protein kinase II delta-subunit isoforms in rats with hypertensive cardiac hypertrophy. Mol Cell Biochem. 2001;220(1\u20132):69\u201376.","journal-title":"Mol Cell Biochem"},{"key":"484_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12933-016-0351-3","volume":"15","author":"TJ Bradley","year":"2016","unstructured":"Bradley TJ, Slorach C, Mahmud FH, Dunger DB, Deanfield J, Deda L, Elia Y, Har RL, Hui W, Moineddin R, et al. Early changes in cardiovascular structure and function in adolescents with type 1 diabetes. Cardiovasc Diabetol. 2016;15:31.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"484_CR10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.59.1.8","volume":"59","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979;59(1):8\u201313.","journal-title":"Circulation"},{"issue":"3","key":"484_CR11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2337\/diacare.27.3.704","volume":"27","author":"CS Fox","year":"2004","unstructured":"Fox CS, Sullivan L, D\u2019Agostino RB Sr, Wilson PW, Framingham Heart S. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care. 2004;27(3):704\u20138.","journal-title":"Diabetes Care"},{"issue":"13","key":"484_CR12","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCULATIONAHA.108.829176","volume":"119","author":"SR Preis","year":"2009","unstructured":"Preis SR, Hwang SJ, Coady S, Pencina MJ, D\u2019Agostino RB Sr, Savage PJ, Levy D, Fox CS. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation. 2009;119(13):1728\u201335.","journal-title":"Circulation"},{"issue":"19","key":"484_CR13","first-page":"788","volume":"57","author":"AC Asmal","year":"1980","unstructured":"Asmal AC, Leary WP, Thandroyen F. Diabetic heart disease. South Afr Med J. 1980;57(19):788\u201390.","journal-title":"South Afr Med J"},{"key":"484_CR14","unstructured":"National Institute of Health: what is diabetic heart disease. https:\/\/www.nhlbi.nih.gov\/health\/health-topics\/topics\/dhd . Accessed 4 Dec 2016."},{"issue":"3","key":"484_CR15","first-page":"296","volume":"92","author":"TH Marwick","year":"2006","unstructured":"Marwick TH. Diabetic heart disease. Heart. 2006;92(3):296\u2013300.","journal-title":"Heart"},{"issue":"11","key":"484_CR16","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.2337\/diab.33.11.1078","volume":"33","author":"V Chen","year":"1984","unstructured":"Chen V, Ianuzzo CD, Fong BC, Spitzer JJ. The effects of acute and chronic diabetes on myocardial metabolism in rats. Diabetes. 1984;33(11):1078\u201384.","journal-title":"Diabetes"},{"issue":"3 Pt 2","key":"484_CR17","first-page":"H837","volume":"264","author":"WT Garvey","year":"1993","unstructured":"Garvey WT, Hardin D, Juhaszova M, Dominguez JH. Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am J Physiol. 1993;264(3 Pt 2):H837\u201344.","journal-title":"Am J Physiol"},{"issue":"7","key":"484_CR18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2337\/diacare.25.7.1135","volume":"25","author":"E Bonora","year":"2002","unstructured":"Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care. 2002;25(7):1135\u201341.","journal-title":"Diabetes Care"},{"issue":"9","key":"484_CR19","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.108.792101","volume":"119","author":"S Boudina","year":"2009","unstructured":"Boudina S, Bugger H, Sena S, O\u2019Neill BT, Zaha VG, Ilkun O, Wright JJ, Mazumder PK, Palfreyman E, Tidwell TJ, et al. Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation. 2009;119(9):1272\u201383.","journal-title":"Circulation"},{"issue":"12","key":"484_CR20","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1210\/en.2005-0938","volume":"146","author":"J Buchanan","year":"2005","unstructured":"Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, Yun UJ, Cooksey RC, Litwin SE, Abel ED. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology. 2005;146(12):5341\u20139.","journal-title":"Endocrinology"},{"issue":"18","key":"484_CR21","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/01.CIR.0000127959.28627.F8","volume":"109","author":"LR Peterson","year":"2004","unstructured":"Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation. 2004;109(18):2191\u20136.","journal-title":"Circulation"},{"issue":"9","key":"484_CR22","doi-asserted-by":"crossref","first-page":"C794","DOI":"10.1152\/ajpcell.00251.2013","volume":"306","author":"H Aguilar","year":"2014","unstructured":"Aguilar H, Fricovsky E, Ihm S, Schimke M, Maya-Ramos L, Aroonsakool N, Ceballos G, Dillmann W, Villarreal F, Ramirez-Sanchez I. Role for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesis. Am J Physiol Cell Physiol. 2014;306(9):C794\u2013804.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7258","key":"484_CR23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405\u201312.","journal-title":"BMJ"},{"issue":"1","key":"484_CR24","doi-asserted-by":"crossref","first-page":"e53247","DOI":"10.1371\/journal.pone.0053247","volume":"8","author":"R Nielsen","year":"2013","unstructured":"Nielsen R, Norrelund H, Kampmann U, Botker HE, Moller N, Wiggers H. Effect of acute hyperglycemia on left ventricular contractile function in diabetic patients with and without heart failure: two randomized cross-over studies. PLoS ONE. 2013;8(1):e53247.","journal-title":"PLoS ONE"},{"issue":"7","key":"484_CR25","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4239\/wjd.v6.i7.943","volume":"6","author":"MT Waddingham","year":"2015","unstructured":"Waddingham MT, Edgley AJ, Tsuchimochi H, Kelly DJ, Shirai M, Pearson JT. Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathy. World J Diabetes. 2015;6(7):943\u201360.","journal-title":"World J Diabetes"},{"issue":"22","key":"484_CR26","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.1073\/pnas.97.22.12222","volume":"97","author":"XL Du","year":"2000","unstructured":"Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA. 2000;97(22):12222\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6779","key":"484_CR27","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","volume":"404","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404(6779):787\u201390.","journal-title":"Nature"},{"issue":"2","key":"484_CR28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2337\/diab.33.2.196","volume":"33","author":"RG Gonzalez","year":"1984","unstructured":"Gonzalez RG, Barnett P, Aguayo J, Cheng HM, Chylack LT Jr. Direct measurement of polyol pathway activity in the ocular lens. Diabetes. 1984;33(2):196\u20139.","journal-title":"Diabetes"},{"issue":"10","key":"484_CR29","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0026-0495(97)90216-X","volume":"46","author":"MC Bravi","year":"1997","unstructured":"Bravi MC, Pietrangeli P, Laurenti O, Basili S, Cassone-Faldetta M, Ferri C, De Mattia G. Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients. Metab Clin Exp. 1997;46(10):1194\u20138.","journal-title":"Metab Clin Exp"},{"issue":"8","key":"484_CR30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0026-0495(94)90175-9","volume":"43","author":"G Mattia De","year":"1994","unstructured":"De Mattia G, Laurenti O, Bravi C, Ghiselli A, Iuliano L, Balsano F. Effect of aldose reductase inhibition on glutathione redox status in erythrocytes of diabetic patients. Metab Clin Exp. 1994;43(8):965\u20138.","journal-title":"Metab Clin Exp"},{"issue":"2","key":"484_CR31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/diab.46.2.292","volume":"46","author":"R Ramasamy","year":"1997","unstructured":"Ramasamy R, Oates PJ, Schaefer S. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury. Diabetes. 1997;46(2):292\u2013300.","journal-title":"Diabetes"},{"issue":"2","key":"484_CR32","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2337\/diacare.27.2.448","volume":"27","author":"BF Johnson","year":"2004","unstructured":"Johnson BF, Nesto RW, Pfeifer MA, Slater WR, Vinik AI, Chyun DA, Law G, Wackers FJ, Young LH. Cardiac abnormalities in diabetic patients with neuropathy: effects of aldose reductase inhibitor administration. Diabetes Care. 2004;27(2):448\u201354.","journal-title":"Diabetes Care"},{"issue":"9","key":"484_CR33","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.2337\/diab.43.9.1122","volume":"43","author":"P Xia","year":"1994","unstructured":"Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes. 1994;43(9):1122\u20139.","journal-title":"Diabetes"},{"issue":"2","key":"484_CR34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI3326","volume":"103","author":"M Igarashi","year":"1999","unstructured":"Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang ZY, Yamauchi T, Kuboki K, Meier M, Rhodes CJ, King GL. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Investig. 1999;103(2):185\u201395.","journal-title":"J Clin Investig"},{"issue":"9","key":"484_CR35","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2337\/diabetes.51.9.2709","volume":"51","author":"KJ Way","year":"2002","unstructured":"Way KJ, Isshiki K, Suzuma K, Yokota T, Zvagelsky D, Schoen FJ, Sandusky GE, Pechous PA, Vlahos CJ, Wakasaki H, et al. Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes. Diabetes. 2002;51(9):2709\u201318.","journal-title":"Diabetes"},{"issue":"11","key":"484_CR36","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1161\/01.ATV.0000144009.35400.65","volume":"24","author":"H Yamaguchi","year":"2004","unstructured":"Yamaguchi H, Igarashi M, Hirata A, Sugae N, Tsuchiya H, Jimbu Y, Tominaga M, Kato T. Altered PDGF-BB-induced p38 MAP kinase activation in diabetic vascular smooth muscle cells: roles of protein kinase C-delta. Arterioscler Thromb Vasc Biol. 2004;24(11):2095\u2013101.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"484_CR37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0008-6363(99)00425-3","volume":"46","author":"Y Hattori","year":"2000","unstructured":"Hattori Y, Hattori S, Sato N, Kasai K. High-glucose-induced nuclear factor kappaB activation in vascular smooth muscle cells. Cardiovasc Res. 2000;46(1):188\u201397.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"484_CR38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/CIRCULATIONAHA.112.127514","volume":"127","author":"CE Tabit","year":"2013","unstructured":"Tabit CE, Shenouda SM, Holbrook M, Fetterman JL, Kiani S, Frame AA, Kluge MA, Held A, Dohadwala MM, Gokce N, et al. Protein kinase C-beta contributes to impaired endothelial insulin signaling in humans with diabetes mellitus. Circulation. 2013;127(1):86\u201395.","journal-title":"Circulation"},{"issue":"2","key":"484_CR39","doi-asserted-by":"crossref","first-page":"e88405","DOI":"10.1371\/journal.pone.0088405","volume":"9","author":"F Chen","year":"2014","unstructured":"Chen F, Yu Y, Haigh S, Johnson J, Lucas R, Stepp DW, Fulton DJ. Regulation of NADPH oxidase 5 by protein kinase C isoforms. PLoS ONE. 2014;9(2):e88405.","journal-title":"PLoS ONE"},{"issue":"11","key":"484_CR40","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2337\/diabetes.49.11.1939","volume":"49","author":"T Inoguchi","year":"2000","unstructured":"Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000;49(11):1939\u201345.","journal-title":"Diabetes"},{"issue":"17","key":"484_CR41","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1073\/pnas.94.17.9320","volume":"94","author":"H Wakasaki","year":"1997","unstructured":"Wakasaki H, Koya D, Schoen FJ, Jirousek MR, Ways DK, Hoit BD, Walsh RA, King GL. Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci USA. 1997;94(17):9320\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6865","key":"484_CR42","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813\u201320.","journal-title":"Nature"},{"issue":"6","key":"484_CR43","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/cvr\/27.6.942","volume":"27","author":"KE Airaksinen","year":"1993","unstructured":"Airaksinen KE, Salmela PI, Linnaluoto MK, Ikaheimo MJ, Ahola K, Ryhanen LJ. Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen. Cardiovasc Res. 1993;27(6):942\u20135.","journal-title":"Cardiovasc Res"},{"issue":"7","key":"484_CR44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.RES.0000065620.39919.20","volume":"92","author":"R Candido","year":"2003","unstructured":"Candido R, Forbes JM, Thomas MC, Thallas V, Dean RG, Burns WC, Tikellis C, Ritchie RH, Twigg SM, Cooper ME, et al. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res. 2003;92(7):785\u201392.","journal-title":"Circ Res"},{"issue":"9","key":"484_CR45","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1016\/S0021-9258(18)68925-2","volume":"263","author":"EC Tsilibary","year":"1988","unstructured":"Tsilibary EC, Charonis AS, Reger LA, Wohlhueter RM, Furcht LT. The effect of nonenzymatic glucosylation on the binding of the main noncollagenous NC1 domain to type IV collagen. J Biol Chem. 1988;263(9):4302\u20138.","journal-title":"J Biol Chem"},{"issue":"8","key":"484_CR46","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/BF00403914","volume":"39","author":"TJ Sims","year":"1996","unstructured":"Sims TJ, Rasmussen LM, Oxlund H, Bailey AJ. The role of glycation cross-links in diabetic vascular stiffening. Diabetologia. 1996;39(8):946\u201351.","journal-title":"Diabetologia"},{"issue":"7","key":"484_CR47","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/hc0702.104183","volume":"105","author":"G Basta","year":"2002","unstructured":"Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C, Kislinger T, Stern DM, Schmidt AM, De Caterina R. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation. 2002;105(7):816\u201322.","journal-title":"Circulation"},{"issue":"26","key":"484_CR48","doi-asserted-by":"crossref","first-page":"16498","DOI":"10.1074\/jbc.272.26.16498","volume":"272","author":"J Li","year":"1997","unstructured":"Li J, Schmidt AM. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem. 1997;272(26):16498\u2013506.","journal-title":"J Biol Chem"},{"issue":"6","key":"484_CR49","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.ATV.21.6.905","volume":"21","author":"T Kislinger","year":"2001","unstructured":"Kislinger T, Tanji N, Wendt T, Qu W, Lu Y, Ferran LJ Jr, Taguchi A, Olson K, Bucciarelli L, Goova M, et al. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol. 2001;21(6):905\u201310.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"22","key":"484_CR50","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1161\/01.CIR.0000039325.03698.36","volume":"106","author":"LG Bucciarelli","year":"2002","unstructured":"Bucciarelli LG, Wendt T, Qu W, Lu Y, Lalla E, Rong LL, Goova MT, Moser B, Kislinger T, Lee DC, et al. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation. 2002;106(22):2827\u201335.","journal-title":"Circulation"},{"issue":"9","key":"484_CR51","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2337\/diabetes.49.9.1561","volume":"49","author":"P Quehenberger","year":"2000","unstructured":"Quehenberger P, Bierhaus A, Fasching P, Muellner C, Klevesath M, Hong M, Stier G, Sattler M, Schleicher E, Speiser W, et al. Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes. 2000;49(9):1561\u201370.","journal-title":"Diabetes"},{"issue":"1\u20132","key":"484_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2012.04.003","volume":"132","author":"T Zitman-Gal","year":"2012","unstructured":"Zitman-Gal T, Golan E, Green J, Bernheim J, Benchetrit S. Vitamin D receptor activation in a diabetic-like environment: potential role in the activity of the endothelial pro-inflammatory and thioredoxin pathways. J Steroid Biochem Mol Biol. 2012;132(1\u20132):1\u20137.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"484_CR53","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s11626-014-9858-7","volume":"51","author":"T Zitman-Gal","year":"2015","unstructured":"Zitman-Gal T, Green J, Korzets Z, Bernheim J, Benchetrit S. Kruppel-like factors in an endothelial and vascular smooth muscle cell coculture model: impact of a diabetic environment and vitamin D. Vitro Cell Dev Biol Anim. 2015;51(5):470\u20138.","journal-title":"Vitro Cell Dev Biol Anim"},{"key":"484_CR54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1475-2840-13-8","volume":"13","author":"T Zitman-Gal","year":"2014","unstructured":"Zitman-Gal T, Green J, Pasmanik-Chor M, Golan E, Bernheim J, Benchetrit S. Vitamin D manipulates miR-181c, miR-20b and miR-15a in human umbilical vein endothelial cells exposed to a diabetic-like environment. Cardiovasc Diabetol. 2014;13:8.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"484_CR55","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.amjcard.2010.11.011","volume":"107","author":"S Raposeiras-Roubin","year":"2011","unstructured":"Raposeiras-Roubin S, Rodino-Janeiro BK, Grigorian-Shamagian L, Moure-Gonzalez M, Seoane-Blanco A, Varela-Roman A, Almenar-Bonet L, Alvarez E, Gonzalez-Juanatey JR. Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score. Am J Cardiol. 2011;107(6):938\u201344.","journal-title":"Am J Cardiol"},{"issue":"12","key":"484_CR56","doi-asserted-by":"crossref","first-page":"904","DOI":"10.47102\/annals-acadmedsg.V39N12p909","volume":"39","author":"P Sarkar","year":"2010","unstructured":"Sarkar P, Kar K, Mondal MC, Chakraborty I, Kar M. Elevated level of carbonyl compounds correlates with insulin resistance in type 2 diabetes. Ann Acad Med Singap. 2010;39(12):904\u20139.","journal-title":"Ann Acad Med Singap"},{"issue":"1","key":"484_CR57","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00329.2005","volume":"290","author":"MG Buse","year":"2006","unstructured":"Buse MG. Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab. 2006;290(1):E1\u20138.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"24","key":"484_CR58","doi-asserted-by":"crossref","first-page":"16283","DOI":"10.1074\/jbc.M802240200","volume":"283","author":"MP Housley","year":"2008","unstructured":"Housley MP, Rodgers JT, Udeshi ND, Kelly TJ, Shabanowitz J, Hunt DF, Puigserver P, Hart GW. O-GlcNAc regulates FoxO activation in response to glucose. J Biol Chem. 2008;283(24):16283\u201392.","journal-title":"J Biol Chem"},{"issue":"7471","key":"484_CR59","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature12537","volume":"502","author":"JR Erickson","year":"2013","unstructured":"Erickson JR, Pereira L, Wang L, Han G, Ferguson A, Dao K, Copeland RJ, Despa F, Hart GW, Ripplinger CM, et al. Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature. 2013;502(7471):372\u20136.","journal-title":"Nature"},{"issue":"8","key":"484_CR60","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1073\/pnas.072072399","volume":"99","author":"K Vosseller","year":"2002","unstructured":"Vosseller K, Wells L, Lane MD, Hart GW. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci USA. 2002;99(8):5313\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"484_CR61","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","volume":"142","author":"K Huynh","year":"2014","unstructured":"Huynh K, Bernardo BC, McMullen JR, Ritchie RH. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol Ther. 2014;142(3):375\u2013415.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"484_CR62","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1152\/physiolgenomics.00016.2011","volume":"44","author":"IG Lunde","year":"2012","unstructured":"Lunde IG, Aronsen JM, Kvaloy H, Qvigstad E, Sjaastad I, Tonnessen T, Christensen G, Gronning-Wang LM, Carlson CR. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure. Physiol Genomics. 2012;44(2):162\u201372.","journal-title":"Physiol Genomics"},{"issue":"1","key":"484_CR63","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/HYPERTENSIONAHA.109.143818","volume":"55","author":"VV Lima","year":"2010","unstructured":"Lima VV, Giachini FR, Carneiro FS, Carneiro ZN, Saleh MA, Pollock DM, Fortes ZB, Carvalho MH, Ergul A, Webb RC, et al. O-GlcNAcylation contributes to augmented vascular reactivity induced by endothelin 1. Hypertension. 2010;55(1):180\u20138.","journal-title":"Hypertension"},{"issue":"11","key":"484_CR64","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.1074\/jbc.272.11.7085","volume":"272","author":"Y Fischer","year":"1997","unstructured":"Fischer Y, Thomas J, Sevilla L, Munoz P, Becker C, Holman G, Kozka IJ, Palacin M, Testar X, Kammermeier H, et al. Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes. Evidence of the existence of different intracellular GLUT4 vesicle populations. J Biol Chem. 1997;272(11):7085\u201392.","journal-title":"J Biol Chem"},{"issue":"30","key":"484_CR65","doi-asserted-by":"crossref","first-page":"17605","DOI":"10.1074\/jbc.271.30.17605","volume":"271","author":"SS Martin","year":"1996","unstructured":"Martin SS, Haruta T, Morris AJ, Klippel A, Williams LT, Olefsky JM. Activated phosphatidylinositol 3-kinase is sufficient to mediate actin rearrangement and GLUT4 translocation in 3T3-L1 adipocytes. J Biol Chem. 1996;271(30):17605\u20138.","journal-title":"J Biol Chem"},{"issue":"13","key":"484_CR66","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1161\/01.CIR.101.13.1539","volume":"101","author":"G Zeng","year":"2000","unstructured":"Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H, Quon MJ. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation. 2000;101(13):1539\u201345.","journal-title":"Circulation"},{"issue":"2","key":"484_CR67","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/01.ATV.20.2.402","volume":"20","author":"C Hermann","year":"2000","unstructured":"Hermann C, Assmus B, Urbich C, Zeiher AM, Dimmeler S. Insulin-mediated stimulation of protein kinase Akt: a potent survival signaling cascade for endothelial cells. Arterioscler Thromb Vasc Biol. 2000;20(2):402\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"484_CR68","doi-asserted-by":"crossref","first-page":"824","DOI":"10.4161\/auto.9099","volume":"5","author":"YT Wu","year":"2009","unstructured":"Wu YT, Tan HL, Huang Q, Ong CN, Shen HM. Activation of the PI3K-Akt-mTOR signaling pathway promotes necrotic cell death via suppression of autophagy. Autophagy. 2009;5(6):824\u201334.","journal-title":"Autophagy"},{"issue":"5","key":"484_CR69","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cmet.2006.04.005","volume":"3","author":"CM Taniguchi","year":"2006","unstructured":"Taniguchi CM, Kondo T, Sajan M, Luo J, Bronson R, Asano T, Farese R, Cantley LC, Kahn CR. Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda\/zeta. Cell Metab. 2006;3(5):343\u201353.","journal-title":"Cell Metab"},{"issue":"6865","key":"484_CR70","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","volume":"414","author":"AR Saltiel","year":"2001","unstructured":"Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414(6865):799\u2013806.","journal-title":"Nature"},{"issue":"1","key":"484_CR71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.cr.7290257","volume":"15","author":"T Zarubin","year":"2005","unstructured":"Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 2005;15(1):11\u20138.","journal-title":"Cell Res"},{"issue":"6","key":"484_CR72","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","volume":"36","author":"MC Mendoza","year":"2011","unstructured":"Mendoza MC, Er EE, Blenis J. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci. 2011;36(6):320\u20138.","journal-title":"Trends Biochem Sci"},{"issue":"5","key":"484_CR73","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/er.2007-0006","volume":"28","author":"R Muniyappa","year":"2007","unstructured":"Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev. 2007;28(5):463\u201391.","journal-title":"Endocr Rev"},{"issue":"4","key":"484_CR74","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1172\/JCI5971","volume":"104","author":"ZY Jiang","year":"1999","unstructured":"Jiang ZY, Lin YW, Clemont A, Feener EP, Hein KD, Igarashi M, Yamauchi T, White MF, King GL. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa\/fa) rats. J Clin Investig. 1999;104(4):447\u201357.","journal-title":"J Clin Investig"},{"issue":"3","key":"484_CR75","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI7535","volume":"105","author":"K Cusi","year":"2000","unstructured":"Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, Mandarino LJ. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Investig. 2000;105(3):311\u201320.","journal-title":"J Clin Investig"},{"key":"484_CR76","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12933-015-0278-0","volume":"14","author":"V Nigris De","year":"2015","unstructured":"De Nigris V, Pujadas G, La Sala L, Testa R, Genovese S, Ceriello A. Short-term high glucose exposure impairs insulin signaling in endothelial cells. Cardiovas Diabetol. 2015;14:114.","journal-title":"Cardiovas Diabetol"},{"issue":"11","key":"484_CR77","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2337\/diab.36.11.1341","volume":"36","author":"JP Felber","year":"1987","unstructured":"Felber JP, Ferrannini E, Golay A, Meyer HU, Theibaud D, Curchod B, Maeder E, Jequier E, DeFronzo RA. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes. 1987;36(11):1341\u201350.","journal-title":"Diabetes"},{"issue":"12","key":"484_CR78","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1172\/JCI118742","volume":"97","author":"M Roden","year":"1996","unstructured":"Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Investig. 1996;97(12):2859\u201365.","journal-title":"J Clin Investig"},{"issue":"9","key":"484_CR79","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.2337\/diabetes.53.9.2366","volume":"53","author":"PK Mazumder","year":"2004","unstructured":"Mazumder PK, O\u2019Neill BT, Roberts MW, Buchanan J, Yun UJ, Cooksey RC, Boudina S, Abel ED. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob\/ob mouse hearts. Diabetes. 2004;53(9):2366\u201374.","journal-title":"Diabetes"},{"issue":"6","key":"484_CR80","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1291\/hypres.31.1157","volume":"31","author":"S Hasegawa","year":"2008","unstructured":"Hasegawa S, Yamamoto K, Sakata Y, Takeda Y, Kajimoto K, Kanai Y, Hori M, Hatazawa J. Effects of cardiac energy efficiency in diastolic heart failure: assessment with positron emission tomography with 11C-acetate. Hypertens Res. 2008;31(6):1157\u201362.","journal-title":"Hypertens Res"},{"issue":"8","key":"484_CR81","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ejheart.2007.05.004","volume":"9","author":"KK Witte","year":"2007","unstructured":"Witte KK, Levy WC, Lindsay KA, Clark AL. Biomechanical efficiency is impaired in patients with chronic heart failure. Eur J Heart Fail. 2007;9(8):834\u20138.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"484_CR82","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1172\/JCI23354","volume":"116","author":"X Du","year":"2006","unstructured":"Du X, Edelstein D, Obici S, Higham N, Zou MH, Brownlee M. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Investig. 2006;116(4):1071\u201380.","journal-title":"J Clin Investig"},{"issue":"10","key":"484_CR83","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.freeradbiomed.2009.08.014","volume":"47","author":"TL Archuleta","year":"2009","unstructured":"Archuleta TL, Lemieux AM, Saengsirisuwan V, Teachey MK, Lindborg KA, Kim JS, Henriksen EJ. Oxidant stress-induced loss of IRS-1 and IRS-2 proteins in rat skeletal muscle: role of p38 MAPK. Free Radic Biol Med. 2009;47(10):1486\u201393.","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"484_CR84","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/ATVBAHA.111.241984","volume":"32","author":"ED Abel","year":"2012","unstructured":"Abel ED, O\u2019Shea KM, Ramasamy R. Insulin resistance: metabolic mechanisms and consequences in the heart. Arterioscler Thromb Vasc Biol. 2012;32(9):2068\u201376.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"484_CR85","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jacc.2007.10.021","volume":"51","author":"RM Witteles","year":"2008","unstructured":"Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol. 2008;51(2):93\u2013102.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"484_CR86","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cvr\/cvp305","volume":"85","author":"N Mariappan","year":"2010","unstructured":"Mariappan N, Elks CM, Sriramula S, Guggilam A, Liu Z, Borkhsenious O, Francis J. NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. Cardiovasc Res. 2010;85(3):473\u201383.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"484_CR87","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1172\/JCI10934","volume":"107","author":"L Rui","year":"2001","unstructured":"Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, Dunaif A, White MF. Insulin\/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Investig. 2001;107(2):181\u20139.","journal-title":"J Clin Investig"},{"issue":"17","key":"484_CR88","doi-asserted-by":"crossref","first-page":"17070","DOI":"10.1074\/jbc.M312021200","volume":"279","author":"C Alvaro de","year":"2004","unstructured":"de Alvaro C, Teruel T, Hernandez R, Lorenzo M. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem. 2004;279(17):17070\u20138.","journal-title":"J Biol Chem"},{"issue":"51","key":"484_CR89","doi-asserted-by":"crossref","first-page":"47944","DOI":"10.1074\/jbc.M104602200","volume":"276","author":"B Emanuelli","year":"2001","unstructured":"Emanuelli B, Peraldi P, Filloux C, Chavey C, Freidinger K, Hilton DJ, Hotamisligil GS, Van Obberghen E. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J Biol Chem. 2001;276(51):47944\u20139.","journal-title":"J Biol Chem"},{"issue":"10","key":"484_CR90","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1172\/JCI11867","volume":"107","author":"JS Campbell","year":"2001","unstructured":"Campbell JS, Prichard L, Schaper F, Schmitz J, Stephenson-Famy A, Rosenfeld ME, Argast GM, Heinrich PC, Fausto N. Expression of suppressors of cytokine signaling during liver regeneration. J Clin Investig. 2001;107(10):1285\u201392.","journal-title":"J Clin Investig"},{"issue":"44","key":"484_CR91","doi-asserted-by":"crossref","first-page":"42394","DOI":"10.1074\/jbc.C200444200","volume":"277","author":"L Rui","year":"2002","unstructured":"Rui L, Yuan M, Frantz D, Shoelson S, White MF. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem. 2002;277(44):42394\u20138.","journal-title":"J Biol Chem"},{"issue":"12","key":"484_CR92","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1128\/MCB.24.12.5434-5446.2004","volume":"24","author":"K Ueki","year":"2004","unstructured":"Ueki K, Kondo T, Kahn CR. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol. 2004;24(12):5434\u201346.","journal-title":"Mol Cell Biol"},{"key":"484_CR93","unstructured":"American Diabetes Association: Can Diabetes Pills Help Me? http:\/\/www.diabetes.org\/living-with-diabetes\/treatment-and-care\/medication\/oral-medications\/can-diabetes-pills-help-me.html . Accessed 4 Dec 2016."},{"key":"484_CR94","unstructured":"American Heart Association: Diabetes Medications. http:\/\/www.heart.org\/HEARTORG\/Conditions\/Diabetes\/PreventionTreatmentofDiabetes\/Diabetes-Medications_UCM_313870_Article.jsp-.VsZleiQTHFI . Accessed 4 Dec 2016."},{"key":"484_CR95","unstructured":"National Institute of Health: How Is Diabetic Heart Disease Treated? http:\/\/www.nhlbi.nih.gov\/health\/health-topics\/topics\/dhd\/treatment . Accessed 4 Dec 2016."},{"issue":"9131","key":"484_CR96","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837\u201353.","journal-title":"Lancet"},{"issue":"24","key":"484_CR97","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"AC Group","year":"2008","unstructured":"Group AC, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560\u201372.","journal-title":"N Engl J Med"},{"issue":"24","key":"484_CR98","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Action to Control Cardiovascular Risk in Diabetes Study G, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545\u201359.","journal-title":"N Engl J Med"},{"issue":"2","key":"484_CR99","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129\u201339.","journal-title":"N Engl J Med"},{"issue":"5","key":"484_CR100","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2213-8587(15)00044-3","volume":"3","author":"JA Udell","year":"2015","unstructured":"Udell JA, Cavender MA, Bhatt DL, Chatterjee S, Farkouh ME, Scirica BM. Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol. 2015;3(5):356\u201366.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"19","key":"484_CR101","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/01.CIR.0000066906.11109.1F","volume":"107","author":"M Tanasescu","year":"2003","unstructured":"Tanasescu M, Leitzmann MF, Rimm EB, Hu FB. Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes. Circulation. 2003;107(19):2435\u20139.","journal-title":"Circulation"},{"issue":"12","key":"484_CR102","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/archinte.163.12.1440","volume":"163","author":"EW Gregg","year":"2003","unstructured":"Gregg EW, Gerzoff RB, Caspersen CJ, Williamson DF, Narayan KM. Relationship of walking to mortality among US adults with diabetes. Arch Intern Med. 2003;163(12):1440\u20137.","journal-title":"Arch Intern Med"},{"issue":"2","key":"484_CR103","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7326\/0003-4819-134-2-200101160-00009","volume":"134","author":"FB Hu","year":"2001","unstructured":"Hu FB, Stampfer MJ, Solomon C, Liu S, Colditz GA, Speizer FE, Willett WC, Manson JE. Physical activity and risk for cardiovascular events in diabetic women. Ann Intern Med. 2001;134(2):96\u2013105.","journal-title":"Ann Intern Med"},{"issue":"11","key":"484_CR104","doi-asserted-by":"crossref","first-page":"e80436","DOI":"10.1371\/journal.pone.0080436","volume":"8","author":"ZC Thent","year":"2013","unstructured":"Thent ZC, Das S, Henry LJ. Role of exercise in the management of diabetes mellitus: the global scenario. PLoS ONE. 2013;8(11):e80436.","journal-title":"PLoS ONE"},{"issue":"1","key":"484_CR105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00125-015-3741-2","volume":"59","author":"S Cassidy","year":"2016","unstructured":"Cassidy S, Thoma C, Hallsworth K, Parikh J, Hollingsworth KG, Taylor R, Jakovljevic DG, Trenell MI. High intensity intermittent exercise improves cardiac structure and function and reduces liver fat in patients with type 2 diabetes: a randomised controlled trial. Diabetologia. 2016;59(1):56\u201366.","journal-title":"Diabetologia"},{"issue":"11","key":"484_CR106","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1249\/mss.0b013e318145b642","volume":"39","author":"P Brassard","year":"2007","unstructured":"Brassard P, Legault S, Garneau C, Bogaty P, Dumesnil JG, Poirier P. Normalization of diastolic dysfunction in type 2 diabetics after exercise training. Med Sci Sports Exerc. 2007;39(11):1896\u2013901.","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"484_CR107","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.metabol.2009.10.011","volume":"59","author":"S Goulopoulou","year":"2010","unstructured":"Goulopoulou S, Baynard T, Franklin RM, Fernhall B, Carhart R Jr, Weinstock R, Kanaley JA. Exercise training improves cardiovascular autonomic modulation in response to glucose ingestion in obese adults with and without type 2 diabetes mellitus. Metab Clin Exp. 2010;59(6):901\u201310.","journal-title":"Metab Clin Exp"},{"issue":"4","key":"484_CR108","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/CIRCULATIONAHA.108.772822","volume":"118","author":"AE Tjonna","year":"2008","unstructured":"Tjonna AE, Lee SJ, Rognmo O, Stolen TO, Bye A, Haram PM, Loennechen JP, Al-Share QY, Skogvoll E, Slordahl SA, et al. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation. 2008;118(4):346\u201354.","journal-title":"Circulation"},{"issue":"16","key":"484_CR109","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.jacc.2014.07.971","volume":"64","author":"SM Hollekim-Strand","year":"2014","unstructured":"Hollekim-Strand SM, Bjorgaas MR, Albrektsen G, Tjonna AE, Wisloff U, Ingul CB. High-intensity interval exercise effectively improves cardiac function in patients with type 2 diabetes mellitus and diastolic dysfunction: a randomized controlled trial. J Am Coll Cardiol. 2014;64(16):1758\u201360.","journal-title":"J Am Coll Cardiol"},{"key":"484_CR110","unstructured":"American Diabetes Association: Aerobic Exercise. http:\/\/www.diabetes.org\/food-and-fitness\/fitness\/types-of-activity\/what-we-recommend.html . Accessed 4 Dec 2016."},{"key":"484_CR111","unstructured":"Diabetes Prevention Program (DPP). http:\/\/www.niddk.nih.gov\/about-niddk\/research-areas\/diabetes\/diabetes-prevention-program-dpp\/Pages\/default.aspx . Accessed 4 Dec 2016."},{"issue":"5","key":"484_CR112","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1152\/japplphysiol.00594.2011","volume":"111","author":"AD Hafstad","year":"2011","unstructured":"Hafstad AD, Boardman NT, Lund J, Hagve M, Khalid AM, Wisloff U, Larsen TS, Aasum E. High intensity interval training alters substrate utilization and reduces oxygen consumption in the heart. J Appl Physiol. 2011;111(5):1235\u201341.","journal-title":"J Appl Physiol"},{"issue":"4","key":"484_CR113","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5099\/aj110400241","volume":"3","author":"S Lee","year":"2011","unstructured":"Lee S, Park Y, Zhang C. Exercise training prevents coronary endothelial dysfunction in type 2 diabetic mice. Am J Biomed Sci. 2011;3(4):241\u201352.","journal-title":"Am J Biomed Sci"},{"issue":"10","key":"484_CR114","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2337\/diacare.25.10.1729","volume":"25","author":"DW Dunstan","year":"2002","unstructured":"Dunstan DW, Daly RM, Owen N, Jolley D, De Courten M, Shaw J, Zimmet P. High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. Diabetes Care. 2002;25(10):1729\u201336.","journal-title":"Diabetes Care"},{"issue":"5","key":"484_CR115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/1479164115590552","volume":"12","author":"R Byrkjeland","year":"2015","unstructured":"Byrkjeland R, Njerve IU, Anderssen S, Arnesen H, Seljeflot I, Solheim S. Effects of exercise training on HbA1c and VO2peak in patients with type 2 diabetes and coronary artery disease: a randomised clinical trial. Diabetes Vasc Dis Res. 2015;12(5):325\u201333.","journal-title":"Diabetes Vasc Dis Res"},{"issue":"2","key":"484_CR116","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3181\/00379727-203-43593","volume":"203","author":"PM DeBlieux","year":"1993","unstructured":"DeBlieux PM, Barbee RW, McDonough KH, Shepherd RE. Exercise training improves cardiac performance in diabetic rats. Proc Soc Exp Biol Med Soc Exp Biol Med. 1993;203(2):209\u201313.","journal-title":"Proc Soc Exp Biol Med Soc Exp Biol Med"},{"issue":"1","key":"484_CR117","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/dmrr.479","volume":"21","author":"TL Broderick","year":"2005","unstructured":"Broderick TL, Poirier P, Gillis M. Exercise training restores abnormal myocardial glucose utilization and cardiac function in diabetes. Diabetes Metab Res Rev. 2005;21(1):44\u201350.","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"484_CR118","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1590\/S0100-879X2000000600004","volume":"33","author":"KL Angelis De","year":"2000","unstructured":"De Angelis KL, Oliveira AR, Dall\u2019Ago P, Peixoto LR, Gadonski G, Lacchini S, Fernandes TG, Irigoyen MC. Effects of exercise training on autonomic and myocardial dysfunction in streptozotocin-diabetic rats. Braz J Med Biol Res. 2000;33(6):635\u201341.","journal-title":"Braz J Med Biol Res"},{"issue":"9","key":"484_CR119","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.cardfail.2012.07.006","volume":"18","author":"B Rodrigues","year":"2012","unstructured":"Rodrigues B, Jorge L, Mostarda CT, Rosa KT, Medeiros A, Malfitano C, de Souza AL Jr, Viegas KA, Lacchini S, Curi R, et al. Aerobic exercise training delays cardiac dysfunction and improves autonomic control of circulation in diabetic rats undergoing myocardial infarction. J Cardiac Fail. 2012;18(9):734\u201344.","journal-title":"J Cardiac Fail"},{"issue":"24","key":"484_CR120","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1161\/CIRCULATIONAHA.106.675041","volume":"115","author":"U Wisloff","year":"2007","unstructured":"Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, Tjonna AE, Helgerud J, Slordahl SA, Lee SJ, et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation. 2007;115(24):3086\u201394.","journal-title":"Circulation"},{"issue":"19","key":"484_CR121","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1001\/jama.2009.681","volume":"301","author":"S Kodama","year":"2009","unstructured":"Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, Sugawara A, Totsuka K, Shimano H, Ohashi Y, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009;301(19):2024\u201335.","journal-title":"JAMA"},{"issue":"11","key":"484_CR122","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.2337\/diacare.26.11.2977","volume":"26","author":"DJ Cuff","year":"2003","unstructured":"Cuff DJ, Meneilly GS, Martin A, Ignaszewski A, Tildesley HD, Frohlich JJ. Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diabetes Care. 2003;26(11):2977\u201382.","journal-title":"Diabetes Care"},{"issue":"3","key":"484_CR123","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2337\/dc06-1149","volume":"30","author":"NP Kadoglou","year":"2007","unstructured":"Kadoglou NP, Perrea D, Iliadis F, Angelopoulou N, Liapis C, Alevizos M. Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes. Diabetes Care. 2007;30(3):719\u201321.","journal-title":"Diabetes Care"},{"issue":"7","key":"484_CR124","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/00005768-200007000-00024","volume":"32","author":"A Albright","year":"2000","unstructured":"Albright A, Franz M, Hornsby G, Kriska A, Marrero D, Ullrich I, Verity LS. American College of Sports Medicine position stand: exercise and type 2 diabetes. Med Sci Sports Exerc. 2000;32(7):1345\u201360.","journal-title":"Med Sci Sports Exerc"},{"issue":"8","key":"484_CR125","doi-asserted-by":"crossref","first-page":"828","DOI":"10.5551\/jat.3798","volume":"17","author":"S Okada","year":"2010","unstructured":"Okada S, Hiuge A, Makino H, Nagumo A, Takaki H, Konishi H, Goto Y, Yoshimasa Y, Miyamoto Y. Effect of exercise intervention on endothelial function and incidence of cardiovascular disease in patients with type 2 diabetes. J Atheroscler Thromb. 2010;17(8):828\u201333.","journal-title":"J Atheroscler Thromb"},{"issue":"3","key":"484_CR126","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.diabres.2007.09.020","volume":"79","author":"ND Cohen","year":"2008","unstructured":"Cohen ND, Dunstan DW, Robinson C, Vulikh E, Zimmet PZ, Shaw JE. Improved endothelial function following a 14-month resistance exercise training program in adults with type 2 diabetes. Diabetes Res Clin Pract. 2008;79(3):405\u201311.","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"484_CR127","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0002-9149(98)00702-4","volume":"82","author":"B Takase","year":"1998","unstructured":"Takase B, Uehata A, Akima T, Nagai T, Nishioka T, Hamabe A, Satomura K, Ohsuzu F, Kurita A. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol. 1998;82(12):1535\u20139 (A1537\u20131538).","journal-title":"Am J Cardiol"},{"issue":"17","key":"484_CR128","first-page":"136","volume":"98","author":"B Kaku","year":"1998","unstructured":"Kaku B, Mizuno S, Ohsato K, Murakami T, Moriuchi I, Arai Y, Nio Y, Takahashi Y. The correlation between coronary stenosis index and flow-mediated dilation of the brachial artery. Circulation. 1998;98(17):136\u2013136.","journal-title":"Circulation"},{"issue":"2","key":"484_CR129","doi-asserted-by":"crossref","first-page":"H306","DOI":"10.1152\/ajpheart.01306.2010","volume":"301","author":"S Lee","year":"2011","unstructured":"Lee S, Park Y, Dellsperger KC, Zhang C. Exercise training improves endothelial function via adiponectin-dependent and independent pathways in type 2 diabetic mice. Am J Physiol Heart Circ Physiol. 2011;301(2):H306\u201314.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"484_CR130","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00125-008-0996-x","volume":"51","author":"F Moien-Afshari","year":"2008","unstructured":"Moien-Afshari F, Ghosh S, Elmi S, Rahman MM, Sallam N, Khazaei M, Kieffer TJ, Brownsey RW, Laher I. Exercise restores endothelial function independently of weight loss or hyperglycaemic status in db\/db mice. Diabetologia. 2008;51(7):1327\u201337.","journal-title":"Diabetologia"},{"issue":"2","key":"484_CR131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jacc.2013.04.031","volume":"62","author":"GA Nichols","year":"2013","unstructured":"Nichols GA, Joshua-Gotlib S, Parasuraman S. Glycemic control and risk of cardiovascular disease hospitalization and all-cause mortality. J Am Coll Cardiol. 2013;62(2):121\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"484_CR132","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1161\/CIRCULATIONAHA.109.192521","volume":"119","author":"TH Marwick","year":"2009","unstructured":"Marwick TH, Hordern MD, Miller T, Chyun DA, Bertoni AG, Blumenthal RS, Philippides G, Rocchini A, Council on Clinical Cardiology AHAECR, Prevention C, et al. Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119(25):3244\u201362.","journal-title":"Circulation"},{"issue":"17","key":"484_CR133","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archinternmed.2012.3130","volume":"172","author":"D Sluik","year":"2012","unstructured":"Sluik D, Buijsse B, Muckelbauer R, Kaaks R, Teucher B, Johnsen NF, Tjonneland A, Overvad K, Ostergaard JN, Amiano P, et al. Physical activity and mortality in individuals with diabetes mellitus: a prospective study and meta-analysis. Arch Intern Med. 2012;172(17):1285\u201395.","journal-title":"Arch Intern Med"},{"issue":"2","key":"484_CR134","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/dc12-0783","volume":"36","author":"S Kodama","year":"2013","unstructured":"Kodama S, Tanaka S, Heianza Y, Fujihara K, Horikawa C, Shimano H, Saito K, Yamada N, Ohashi Y, Sone H. Association between physical activity and risk of all-cause mortality and cardiovascular disease in patients with diabetes: a meta-analysis. Diabetes Care. 2013;36(2):471\u20139.","journal-title":"Diabetes Care"},{"issue":"3","key":"484_CR135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2337\/diacare.20.3.385","volume":"20","author":"A Mourier","year":"1997","unstructured":"Mourier A, Gautier JF, De Kerviler E, Bigard AX, Villette JM, Garnier JP, Duvallet A, Guezennec CY, Cathelineau G. Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM: effects of branched-chain amino acid supplements. Diabetes Care. 1997;20(3):385\u201391.","journal-title":"Diabetes Care"},{"issue":"6","key":"484_CR136","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/HJR.0b013e3282efaf50","volume":"14","author":"NP Kadoglou","year":"2007","unstructured":"Kadoglou NP, Iliadis F, Angelopoulou N, Perrea D, Ampatzidis G, Liapis CD, Alevizos M. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. Eur J Cardiovasc Prev Rehabil. 2007;14(6):837\u201343.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"10","key":"484_CR137","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2337\/diacare.20.10.1503","volume":"20","author":"TD Agurs-Collins","year":"1997","unstructured":"Agurs-Collins TD, Kumanyika SK, Ten Have TR, Adams-Campbell LL. A randomized controlled trial of weight reduction and exercise for diabetes management in older African-American subjects. Diabetes Care. 1997;20(10):1503\u201311.","journal-title":"Diabetes Care"},{"issue":"6","key":"484_CR138","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2337\/diacare.20.6.913","volume":"20","author":"DW Dunstan","year":"1997","unstructured":"Dunstan DW, Mori TA, Puddey IB, Beilin LJ, Burke V, Morton AR, Stanton KG. The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM: a randomized controlled study. Diabetes Care. 1997;20(6):913\u201321.","journal-title":"Diabetes Care"},{"issue":"6","key":"484_CR139","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/dc13-2900","volume":"37","author":"CL Rock","year":"2014","unstructured":"Rock CL, Flatt SW, Pakiz B, Taylor KS, Leone AF, Brelje K, Heath DD, Quintana EL, Sherwood NE. Weight loss, glycemic control, and cardiovascular disease risk factors in response to differential diet composition in a weight loss program in type 2 diabetes: a randomized controlled trial. Diabetes Care. 2014;37(6):1573\u201380.","journal-title":"Diabetes Care"},{"issue":"7","key":"484_CR140","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc10-2415","volume":"34","author":"RR Wing","year":"2011","unstructured":"Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, Hill JO, Brancati FL, Peters A, Wagenknecht L, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34(7):1481\u20136.","journal-title":"Diabetes Care"},{"issue":"2","key":"484_CR141","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2337\/diabetes.53.2.294","volume":"53","author":"MK Holten","year":"2004","unstructured":"Holten MK, Zacho M, Gaster M, Juel C, Wojtaszewski JF, Dela F. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes. 2004;53(2):294\u2013305.","journal-title":"Diabetes"},{"issue":"9","key":"484_CR142","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.2337\/db10-0233","volume":"59","author":"HP Lauritzen","year":"2010","unstructured":"Lauritzen HP, Galbo H, Toyoda T, Goodyear LJ. Kinetics of contraction-induced GLUT4 translocation in skeletal muscle fibers from living mice. Diabetes. 2010;59(9):2134\u201344.","journal-title":"Diabetes"},{"issue":"1","key":"484_CR143","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jjcc.2008.07.014","volume":"53","author":"M Oguri","year":"2009","unstructured":"Oguri M, Adachi H, Ohno T, Oshima S, Kurabayashi M. Effect of a single bout of moderate exercise on glucose uptake in type 2 diabetes mellitus. J Cardiol. 2009;53(1):8\u201314.","journal-title":"J Cardiol"},{"issue":"4","key":"484_CR144","doi-asserted-by":"crossref","first-page":"e61604","DOI":"10.1371\/journal.pone.0061604","volume":"8","author":"E Sai","year":"2013","unstructured":"Sai E, Shimada K, Yokoyama T, Sato S, Miyazaki T, Hiki M, Tamura Y, Aoki S, Watada H, Kawamori R, et al. Association between myocardial triglyceride content and cardiac function in healthy subjects and endurance athletes. PLoS ONE. 2013;8(4):e61604.","journal-title":"PLoS ONE"},{"key":"484_CR145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1475-2840-10-47","volume":"10","author":"VB Schrauwen-Hinderling","year":"2011","unstructured":"Schrauwen-Hinderling VB, Meex RC, Hesselink MK, van de Weijer T, Leiner T, Schar M, Lamb HJ, Wildberger JE, Glatz JF, Schrauwen P, et al. Cardiac lipid content is unresponsive to a physical activity training intervention in type 2 diabetic patients, despite improved ejection fraction. Cardiovasc Diabetol. 2011;10:47.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"484_CR146","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.2337\/db12-1580","volume":"62","author":"AD Hafstad","year":"2013","unstructured":"Hafstad AD, Lund J, Hadler-Olsen E, Hoper AC, Larsen TS, Aasum E. High- and moderate-intensity training normalizes ventricular function and mechanoenergetics in mice with diet-induced obesity. Diabetes. 2013;62(7):2287\u201394.","journal-title":"Diabetes"},{"issue":"3","key":"484_CR147","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1152\/jappl.1997.82.3.828","volume":"82","author":"BA Osborn","year":"1997","unstructured":"Osborn BA, Daar JT, Laddaga RA, Romano FD, Paulson DJ. Exercise training increases sarcolemmal GLUT-4 protein and mRNA content in diabetic heart. J Appl Physiol. 1997;82(3):828\u201334.","journal-title":"J Appl Physiol"},{"issue":"3","key":"484_CR148","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00421-004-1214-2","volume":"93","author":"HJ Kim","year":"2004","unstructured":"Kim HJ, Lee JS, Kim CK. Effect of exercise training on muscle glucose transporter 4 protein and intramuscular lipid content in elderly men with impaired glucose tolerance. Eur J Appl Physiol. 2004;93(3):353\u20138.","journal-title":"Eur J Appl Physiol"},{"issue":"6","key":"484_CR149","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1172\/JCI113822","volume":"82","author":"EW Gertz","year":"1988","unstructured":"Gertz EW, Wisneski JA, Stanley WC, Neese RA. Myocardial substrate utilization during exercise in humans: dual carbon-labeled carbohydrate isotope experiments. J Clin Investig. 1988;82(6):2017\u201325.","journal-title":"J Clin Investig"},{"issue":"9","key":"484_CR150","first-page":"1043","volume":"41","author":"K Sato","year":"1993","unstructured":"Sato K, Nishinaka Y, Morishita Y, Nakane K, Fukatsu T, Yokota M, Nakashima N. Myocardial metabolism during dynamic exercise. Rinsho Byori Jpn J Clin Pathol. 1993;41(9):1043\u20138.","journal-title":"Rinsho Byori Jpn J Clin Pathol"},{"issue":"5","key":"484_CR151","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.ATV.0000122852.22604.78","volume":"24","author":"A Ceriello","year":"2004","unstructured":"Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc. 2004;24(5):816\u201323.","journal-title":"Arterioscler Thromb Vasc"},{"issue":"2","key":"484_CR152","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/path.4113","volume":"229","author":"DM Ansley","year":"2013","unstructured":"Ansley DM, Wang B. Oxidative stress and myocardial injury in the diabetic heart. J Pathol. 2013;229(2):232\u201341.","journal-title":"J Pathol"},{"issue":"2","key":"484_CR153","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.metabol.2007.08.021","volume":"57","author":"H Nojima","year":"2008","unstructured":"Nojima H, Watanabe H, Yamane K, Kitahara Y, Sekikawa K, Yamamoto H, Yokoyama A, Inamizu T, Asahara T, Kohno N, et al. Effect of aerobic exercise training on oxidative stress in patients with type 2 diabetes mellitus. Metab Clin Exp. 2008;57(2):170\u20136.","journal-title":"Metab Clin Exp"},{"issue":"3","key":"484_CR154","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/07435800.2011.566236","volume":"36","author":"S Kurban","year":"2011","unstructured":"Kurban S, Mehmetoglu I, Yerlikaya HF, Gonen S, Erdem S. Effect of chronic regular exercise on serum ischemia-modified albumin levels and oxidative stress in type 2 diabetes mellitus. Endocr Res. 2011;36(3):116\u201323.","journal-title":"Endocr Res"},{"key":"484_CR155","doi-asserted-by":"crossref","first-page":"9238","DOI":"10.1038\/srep09238","volume":"5","author":"G Vinetti","year":"2015","unstructured":"Vinetti G, Mozzini C, Desenzani P, Boni E, Bulla L, Lorenzetti I, Romano C, Pasini A, Cominacini L, Assanelli D. Supervised exercise training reduces oxidative stress and cardiometabolic risk in adults with type 2 diabetes: a randomized controlled trial. Sci Rep. 2015;5:9238.","journal-title":"Sci Rep"},{"issue":"10","key":"484_CR156","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.2337\/dc10-2430","volume":"34","author":"SV Hegde","year":"2011","unstructured":"Hegde SV, Adhikari P, Kotian S, Pinto VJ, D\u2019Souza S, D\u2019Souza V. Effect of 3-month yoga on oxidative stress in type 2 diabetes with or without complications: a controlled clinical trial. Diabetes Care. 2011;34(10):2208\u201310.","journal-title":"Diabetes Care"},{"issue":"6","key":"484_CR157","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1600-0838.2007.00748.x","volume":"18","author":"RT Iborra","year":"2008","unstructured":"Iborra RT, Ribeiro IC, Neves MQ, Charf AM, Lottenberg SA, Negrao CE, Nakandakare ER, Passarelli M. Aerobic exercise training improves the role of high-density lipoprotein antioxidant and reduces plasma lipid peroxidation in type 2 diabetes mellitus. Scand J Med Sci Sports. 2008;18(6):742\u201350.","journal-title":"Scand J Med Sci Sports"},{"issue":"2","key":"484_CR158","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2310\/JIM.0000000000000025","volume":"62","author":"MJ Neuparth","year":"2014","unstructured":"Neuparth MJ, Proenca JB, Santos-Silva A, Coimbra S. The positive effect of moderate walking exercise on chemerin levels in Portuguese patients with type 2 diabetes mellitus. J Investig Med. 2014;62(2):350\u20133.","journal-title":"J Investig Med"},{"key":"484_CR159","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6882-8-21","volume":"8","author":"LA Gordon","year":"2008","unstructured":"Gordon LA, Morrison EY, McGrowder DA, Young R, Fraser YT, Zamora EM, Alexander-Lindo RL, Irving RR. Effect of exercise therapy on lipid profile and oxidative stress indicators in patients with type 2 diabetes. BMC Complement Altern Med. 2008;8:21.","journal-title":"BMC Complement Altern Med"},{"issue":"2","key":"484_CR160","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1152\/japplphysiol.01183.2003","volume":"97","author":"M Atalay","year":"2004","unstructured":"Atalay M, Oksala NK, Laaksonen DE, Khanna S, Nakao C, Lappalainen J, Roy S, Hanninen O, Sen CK. Exercise training modulates heat shock protein response in diabetic rats. J Appl Physiol. 2004;97(2):605\u201311.","journal-title":"J Appl Physiol"},{"issue":"2","key":"484_CR161","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.freeradbiomed.2011.10.440","volume":"52","author":"VR Muthusamy","year":"2012","unstructured":"Muthusamy VR, Kannan S, Sadhaasivam K, Gounder SS, Davidson CJ, Boeheme C, Hoidal JR, Wang L, Rajasekaran NS. Acute exercise stress activates Nrf2\/ARE signaling and promotes antioxidant mechanisms in the myocardium. Free Radic Biol Med. 2012;52(2):366\u201376.","journal-title":"Free Radic Biol Med"},{"issue":"4\u20135","key":"484_CR162","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.clinbiochem.2009.11.018","volume":"43","author":"M Kaefer","year":"2010","unstructured":"Kaefer M, Piva SJ, De Carvalho JA, Da Silva DB, Becker AM, Coelho AC, Duarte MM, Moresco RN. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clin Biochem. 2010;43(4\u20135):450\u20134.","journal-title":"Clin Biochem"},{"issue":"10","key":"484_CR163","first-page":"1677","volume":"66","author":"SG Ma","year":"2011","unstructured":"Ma SG, Wei CL, Hong B, Yu WN. Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease. Clinics. 2011;66(10):1677\u201380.","journal-title":"Clinics"},{"issue":"1","key":"484_CR164","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/emj.2003.006007","volume":"21","author":"MK Sinha","year":"2004","unstructured":"Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of \u201cIschemia modified albumin\u201d, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J. 2004;21(1):29\u201334.","journal-title":"Emerg Med J"},{"issue":"7","key":"484_CR165","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.2337\/dc11-0469","volume":"34","author":"T Vepsalainen","year":"2011","unstructured":"Vepsalainen T, Soinio M, Marniemi J, Lehto S, Juutilainen A, Laakso M, Ronnemaa T. Physical activity, high-sensitivity C-reactive protein, and total and cardiovascular disease mortality in type 2 diabetes. Diabetes Care. 2011;34(7):1492\u20136.","journal-title":"Diabetes Care"},{"issue":"6","key":"484_CR166","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487\u201395.","journal-title":"Diabetes Care"},{"issue":"7","key":"484_CR167","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.CIR.0000155620.10387.43","volume":"111","author":"MP Reilly","year":"2005","unstructured":"Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005;111(7):932\u20139.","journal-title":"Circulation"},{"issue":"1","key":"484_CR168","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cardfail.2010.08.007","volume":"17","author":"MH Zhang","year":"2011","unstructured":"Zhang MH, Na B, Schiller NB, Whooley MA. Association of resistin with heart failure and mortality in patients with stable coronary heart disease: data from the heart and soul study. J Cardiac Fail. 2011;17(1):24\u201330.","journal-title":"J Cardiac Fail"},{"issue":"2","key":"484_CR169","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2337\/diabetes.51.2.479","volume":"51","author":"KF Howlett","year":"2002","unstructured":"Howlett KF, Sakamoto K, Hirshman MF, Aschenbach WG, Dow M, White MF, Goodyear LJ. Insulin signaling after exercise in insulin receptor substrate-2-deficient mice. Diabetes. 2002;51(2):479\u201383.","journal-title":"Diabetes"},{"issue":"2","key":"484_CR170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/hrt.2003.027094","volume":"91","author":"B Huisamen","year":"2005","unstructured":"Huisamen B, Lochner A. Exercise modulates myocardial protein kinase B\/Akt in Zucker obese rats. Heart. 2005;91(2):227\u20138.","journal-title":"Heart"},{"issue":"1","key":"484_CR171","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1530\/eje.0.1470149","volume":"147","author":"E Luciano","year":"2002","unstructured":"Luciano E, Carneiro EM, Carvalho CR, Carvalheira JB, Peres SB, Reis MA, Saad MJ, Boschero AC, Velloso LA. Endurance training improves responsiveness to insulin and modulates insulin signal transduction through the phosphatidylinositol 3-kinase\/Akt-1 pathway. Eur J Endocrinol. 2002;147(1):149\u201357.","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"484_CR172","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.2337\/db13-1686","volume":"63","author":"CM Castorena","year":"2014","unstructured":"Castorena CM, Arias EB, Sharma N, Cartee GD. Postexercise improvement in insulin-stimulated glucose uptake occurs concomitant with greater AS160 phosphorylation in muscle from normal and insulin-resistant rats. Diabetes. 2014;63(7):2297\u2013308.","journal-title":"Diabetes"},{"issue":"6","key":"484_CR173","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1159\/000374021","volume":"35","author":"H Wang","year":"2015","unstructured":"Wang H, Bei Y, Lu Y, Sun W, Liu Q, Wang Y, Cao Y, Chen P, Xiao J, Kong X. Exercise prevents cardiac injury and improves mitochondrial biogenesis in advanced diabetic cardiomyopathy with PGC-1alpha and Akt activation. Cell Physiol Biochem. 2015;35(6):2159\u201368.","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"484_CR174","doi-asserted-by":"crossref","first-page":"E925","DOI":"10.1152\/ajpendo.00429.2005","volume":"290","author":"A Sriwijitkamol","year":"2006","unstructured":"Sriwijitkamol A, Ivy JL, Christ-Roberts C, DeFronzo RA, Mandarino LJ, Musi N. LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training. Am J Physiol Endocrinol Metab. 2006;290(5):E925\u201332.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"484_CR175","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1002\/jcp.23037","volume":"227","author":"R Marinho","year":"2012","unstructured":"Marinho R, Ropelle ER, Cintra DE, De Souza CT, Da Silva AS, Bertoli FC, Colantonio E, D\u2019Almeida V, Pauli JR. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss. J Cell Physiol. 2012;227(7):2917\u201326.","journal-title":"J Cell Physiol"},{"key":"484_CR176","doi-asserted-by":"publisher","DOI":"10.2337\/db16-0530","author":"R Kjobsted","year":"2016","unstructured":"Kjobsted R, Munk-Hansen N, Birk JB, Foretz M, Viollet B, Bjornholm M, Zierath JR, Treebak JT, Wojtaszewski JF. Enhanced Muscle Insulin Sensitivity After Contraction\/Exercise is Mediated by AMPK. Diab. 2016. doi: 10.2337\/db16-0530 .","journal-title":"Diab"},{"key":"484_CR177","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12933-015-0251-y","volume":"14","author":"EA Bradley","year":"2015","unstructured":"Bradley EA, Zhang L, Genders AJ, Richards SM, Rattigan S, Keske MA. Enhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside. Cardiovasc Diabetol. 2015;14:91.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"484_CR178","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1074\/jbc.C100631200","volume":"277","author":"J Lin","year":"2002","unstructured":"Lin J, Puigserver P, Donovan J, Tarr P, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta), a novel PGC-1-related transcription coactivator associated with host cell factor. J Biol Chem. 2002;277(3):1645\u20138.","journal-title":"J Biol Chem"},{"issue":"2","key":"484_CR179","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/cvr\/cvn098","volume":"79","author":"R Ventura-Clapier","year":"2008","unstructured":"Ventura-Clapier R, Garnier A, Veksler V. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc Res. 2008;79(2):208\u201317.","journal-title":"Cardiovasc Res"},{"issue":"12 Pt B","key":"484_CR180","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.bbalip.2016.05.006","volume":"1861","author":"J Massart","year":"2016","unstructured":"Massart J, Katayama M, Krook A. microManaging glucose and lipid metabolism in skeletal muscle: role of microRNAs. Biochim Biophys Acta. 2016;1861(12 Pt B):2130\u20138.","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"484_CR181","doi-asserted-by":"crossref","first-page":"9635","DOI":"10.1073\/pnas.1207287109","volume":"109","author":"S Kleiner","year":"2012","unstructured":"Kleiner S, Mepani RJ, Laznik D, Ye L, Jurczak MJ, Jornayvaz FR, Estall JL, Chatterjee Bhowmick D, Shulman GI, Spiegelman BM. Development of insulin resistance in mice lacking PGC-1alpha in adipose tissues. Proc Natl Acad Sci USA. 2012;109(24):9635\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"484_CR182","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2337\/db12-0291","volume":"62","author":"S Summermatter","year":"2013","unstructured":"Summermatter S, Shui G, Maag D, Santos G, Wenk MR, Handschin C. PGC-1alpha improves glucose homeostasis in skeletal muscle in an activity-dependent manner. Diabetes. 2013;62(1):85\u201395.","journal-title":"Diabetes"},{"issue":"50","key":"484_CR183","doi-asserted-by":"crossref","first-page":"21401","DOI":"10.1073\/pnas.0909131106","volume":"106","author":"J Chinsomboon","year":"2009","unstructured":"Chinsomboon J, Ruas J, Gupta RK, Thom R, Shoag J, Rowe GC, Sawada N, Raghuram S, Arany Z. The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle. Proc Natl Acad Sci USA. 2009;106(50):21401\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"484_CR184","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.molmet.2015.09.006","volume":"4","author":"K Marcinko","year":"2015","unstructured":"Marcinko K, Sikkema SR, Samaan MC, Kemp BE, Fullerton MD, Steinberg GR. High intensity interval training improves liver and adipose tissue insulin sensitivity. Mol Metab. 2015;4(12):903\u201315.","journal-title":"Mol Metab"},{"issue":"29","key":"484_CR185","doi-asserted-by":"crossref","first-page":"12017","DOI":"10.1073\/pnas.0705070104","volume":"104","author":"S Jager","year":"2007","unstructured":"Jager S, Handschin C, St-Pierre J, Spiegelman BM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci USA. 2007;104(29):12017\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"484_CR186","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1139\/apnm-2012-0257","volume":"38","author":"D Hoshino","year":"2013","unstructured":"Hoshino D, Yoshida Y, Kitaoka Y, Hatta H, Bonen A. High-intensity interval training increases intrinsic rates of mitochondrial fatty acid oxidation in rat red and white skeletal muscle. Appl Physiol Nutr Metab. 2013;38(3):326\u201333.","journal-title":"Appl Physiol Nutr Metab"},{"issue":"4","key":"484_CR187","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/db15-1231","volume":"65","author":"A Mehlem","year":"2016","unstructured":"Mehlem A, Palombo I, Wang X, Hagberg CE, Eriksson U, Falkevall A. PGC-1alpha coordinates mitochondrial respiratory capacity and muscular fatty acid uptake via regulation of VEGF-B. Diabetes. 2016;65(4):861\u201373.","journal-title":"Diabetes"},{"issue":"2","key":"484_CR188","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1152\/jappl.2000.88.2.797","volume":"88","author":"JP Kirwan","year":"2000","unstructured":"Kirwan JP, del Aguila LF, Hernandez JM, Williamson DL, O\u2019Gorman DJ, Lewis R, Krishnan RK. Regular exercise enhances insulin activation of IRS-1-associated PI3-kinase in human skeletal muscle. J Appl Physiol. 2000;88(2):797\u2013803.","journal-title":"J Appl Physiol"},{"issue":"2","key":"484_CR189","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1152\/jappl.2001.90.2.436","volume":"90","author":"GD Wadley","year":"2001","unstructured":"Wadley GD, Tunstall RJ, Sanigorski A, Collier GR, Hargreaves M, Cameron-Smith D. Differential effects of exercise on insulin-signaling gene expression in human skeletal muscle. J Appl Physiol. 2001;90(2):436\u201340.","journal-title":"J Appl Physiol"},{"issue":"9","key":"484_CR190","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.metabol.2011.01.006","volume":"60","author":"ML Jorge","year":"2011","unstructured":"Jorge ML, de Oliveira VN, Resende NM, Paraiso LF, Calixto A, Diniz AL, Resende ES, Ropelle ER, Carvalheira JB, Espindola FS, et al. The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus. Metab Clin Exp. 2011;60(9):1244\u201352.","journal-title":"Metab Clin Exp"},{"key":"484_CR191","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1475-2840-13-44","volume":"13","author":"S Rawal","year":"2014","unstructured":"Rawal S, Manning P, Katare R. Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease. Cardiovasc Diabetol. 2014;13:44.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"484_CR192","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","volume":"104","author":"RF Duisters","year":"2009","unstructured":"Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE, Schellings MW, Barenbrug P, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res. 2009;104(2):170\u20138 (176p following 178).","journal-title":"Circ Res"},{"issue":"1","key":"484_CR193","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/dmrr.1054","volume":"26","author":"B Feng","year":"2010","unstructured":"Feng B, Chen S, George B, Feng Q, Chakrabarti S. miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev. 2010;26(1):40\u20139.","journal-title":"Diabetes Metab Res Rev"},{"issue":"12","key":"484_CR194","doi-asserted-by":"crossref","first-page":"e28324","DOI":"10.1371\/journal.pone.0028324","volume":"6","author":"AE Belevych","year":"2011","unstructured":"Belevych AE, Sansom SE, Terentyeva R, Ho HT, Nishijima Y, Martin MM, Jindal HK, Rochira JA, Kunitomo Y, Abdellatif M, et al. MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex. PLoS ONE. 2011;6(12):e28324.","journal-title":"PLoS ONE"},{"issue":"3","key":"484_CR195","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/jcmm.12218","volume":"18","author":"S Chen","year":"2014","unstructured":"Chen S, Puthanveetil P, Feng B, Matkovich SJ, Dorn GW 2nd, Chakrabarti S. Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes. J Cell Mol Med. 2014;18(3):415\u201321.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"484_CR196","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.stemcr.2014.10.010","volume":"3","author":"A Izarra","year":"2014","unstructured":"Izarra A, Moscoso I, Levent E, Canon S, Cerrada I, Diez-Juan A, Blanca V, Nunez-Gil IJ, Valiente I, Ruiz-Sauri A, et al. miR-133a enhances the protective capacity of cardiac progenitors cells after myocardial infarction. Stem Cell Rep. 2014;3(6):1029\u201342.","journal-title":"Stem Cell Rep"},{"key":"484_CR197","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1423-0127-18-22","volume":"18","author":"B He","year":"2011","unstructured":"He B, Xiao J, Ren AJ, Zhang YF, Zhang H, Chen M, Xie B, Gao XG, Wang YW. Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J Biomed Sci. 2011;18:22.","journal-title":"J Biomed Sci"},{"issue":"Pt 18","key":"484_CR198","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1113\/jphysiol.2013.255695","volume":"591","author":"AP Russell","year":"2013","unstructured":"Russell AP, Lamon S, Boon H, Wada S, Guller I, Brown EL, Chibalin AV, Zierath JR, Snow RJ, Stepto N, et al. Regulation of miRNAs in human skeletal muscle following acute endurance exercise and short-term endurance training. J Physiol. 2013;591(Pt 18):4637\u201353.","journal-title":"J Physiol"},{"issue":"Pt 20","key":"484_CR199","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1113\/jphysiol.2010.189860","volume":"588","author":"S Nielsen","year":"2010","unstructured":"Nielsen S, Scheele C, Yfanti C, Akerstrom T, Nielsen AR, Pedersen BK, Laye MJ. Muscle specific microRNAs are regulated by endurance exercise in human skeletal muscle. J Physiol. 2010;588(Pt 20):4029\u201337.","journal-title":"J Physiol"},{"issue":"4","key":"484_CR200","doi-asserted-by":"crossref","first-page":"H557","DOI":"10.1152\/ajpheart.00711.2013","volume":"306","author":"FC Mooren","year":"2014","unstructured":"Mooren FC, Viereck J, Kruger K, Thum T. Circulating micrornas as potential biomarkers of aerobic exercise capacity. Am J Physiol-Heart C. 2014;306(4):H557\u201363.","journal-title":"Am J Physiol-Heart C"},{"issue":"2","key":"484_CR201","doi-asserted-by":"crossref","first-page":"e87308","DOI":"10.1371\/journal.pone.0087308","volume":"9","author":"S Nielsen","year":"2014","unstructured":"Nielsen S, Akerstrom T, Rinnov A, Yfanti C, Scheele C, Pedersen BK, Laye MJ. The miRNA plasma signature in response to acute aerobic exercise and endurance training. PLoS ONE. 2014;9(2):e87308.","journal-title":"PLoS ONE"},{"issue":"4","key":"484_CR202","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1177\/2047487312467902","volume":"21","author":"M Uhlemann","year":"2014","unstructured":"Uhlemann M, Mobius-Winkler S, Fikenzer S, Adam J, Redlich M, Mohlenkamp S, Hilberg T, Schuler GC, Adams V. Circulating microRNA-126 increases after different forms of endurance exercise in healthy adults. Eur J Prev Cardiol. 2014;21(4):484\u201391.","journal-title":"Eur J Prev Cardiol"},{"key":"484_CR203","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1096\/fasebj.25.1_supplement.1032.4","volume":"25","author":"PK Mishra","year":"2011","unstructured":"Mishra PK, Awe O, Metreveli N, Qipshidze N, Munjal C, Tyagi N, Tyagi SC. Exercise ameliorates diabetic cardiomyopathy by inducing beta2-adrenergic receptors and miR-133a, and attenuating MMP-9. Faseb J. 2011;25:1032\u20134.","journal-title":"Faseb J"},{"issue":"Pt 1","key":"484_CR204","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1469-7793.2000.00237.x","volume":"529","author":"A Steensberg","year":"2000","unstructured":"Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, Pedersen BK. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol. 2000;529(Pt 1):237\u201342.","journal-title":"J Physiol"},{"issue":"6","key":"484_CR205","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.2337\/db06-1733","volume":"56","author":"S Glund","year":"2007","unstructured":"Glund S, Deshmukh A, Long YC, Moller T, Koistinen HA, Caidahl K, Zierath JR, Krook A. Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes. 2007;56(6):1630\u20137.","journal-title":"Diabetes"},{"key":"484_CR206","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijcard.2015.08.161","volume":"202","author":"S Rawal","year":"2016","unstructured":"Rawal S, Ram TP, Coffey S, Williams MJ, Saxena P, Bunton RW, Galvin IF, Katare R. Differential expression pattern of cardiovascular microRNAs in the human type-2 diabetic heart with normal ejection fraction. Int J Cardiol. 2016;202:40\u20133.","journal-title":"Int J Cardiol"},{"issue":"3","key":"484_CR207","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s12013-013-9672-y","volume":"67","author":"SS Yildirim","year":"2013","unstructured":"Yildirim SS, Akman D, Catalucci D, Turan B. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1. Cell Biochem Biophys. 2013;67(3):1397\u2013408.","journal-title":"Cell Biochem Biophys"},{"issue":"4","key":"484_CR208","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.yjmcc.2008.01.012","volume":"44","author":"CS Hong","year":"2008","unstructured":"Hong CS, Kwon SJ, Cho MC, Kwak YG, Ha KC, Hong B, Li H, Chae SW, Chai OH, Song CH, et al. Overexpression of junctate induces cardiac hypertrophy and arrhythmia via altered calcium handling. J Mol Cell Cardiol. 2008;44(4):672\u201382.","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"484_CR209","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ceca.2005.10.004","volume":"39","author":"U Kirchhefer","year":"2006","unstructured":"Kirchhefer U, Hanske G, Jones LR, Justus I, Kaestner L, Lipp P, Schmitz W, Neumann J. Overexpression of junction causes adaptive changes in cardiac myocyte Ca(2+) signaling. Cell Calcium. 2006;39(2):131\u201342.","journal-title":"Cell Calcium"},{"issue":"4","key":"484_CR210","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4161\/rna.28300","volume":"11","author":"J Wang","year":"2014","unstructured":"Wang J, Jia Z, Zhang C, Sun M, Wang W, Chen P, Ma K, Zhang Y, Li X, Zhou C. miR-499 protects cardiomyocytes from H2O2-induced apoptosis via its effects on Pdcd4 and Pacs2. RNA Biol. 2014;11(4):339\u201350.","journal-title":"RNA Biol"},{"issue":"4","key":"484_CR211","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCRESAHA.108.185363","volume":"104","author":"X Liu","year":"2009","unstructured":"Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res. 2009;104(4):476\u201387.","journal-title":"Circ Res"},{"issue":"7","key":"484_CR212","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1007\/s00125-011-2125-5","volume":"54","author":"G Togliatto","year":"2011","unstructured":"Togliatto G, Trombetta A, Dentelli P, Rosso A, Brizzi MF. MIR221\/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated vascular cell damage. Diabetologia. 2011;54(7):1930\u201340.","journal-title":"Diabetologia"},{"key":"484_CR213","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1038\/srep05026","volume":"4","author":"Y Jiang","year":"2014","unstructured":"Jiang Y, Wang HY, Li Y, Guo SH, Zhang L, Cai JH. Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases. Sci Rep. 2014;4:5026.","journal-title":"Sci Rep"},{"issue":"4","key":"484_CR214","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cmet.2015.02.014","volume":"21","author":"X Liu","year":"2015","unstructured":"Liu X, Xiao J, Zhu H, Wei X, Platt C, Damilano F, Xiao C, Bezzerides V, Bostrom P, Che L, et al. miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell Metab. 2015;21(4):584\u201395.","journal-title":"Cell Metab"},{"issue":"2","key":"484_CR215","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.devcel.2008.07.008","volume":"15","author":"JE Fish","year":"2008","unstructured":"Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008;15(2):272\u201384.","journal-title":"Dev Cell"},{"issue":"2","key":"484_CR216","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.devcel.2008.07.002","volume":"15","author":"S Wang","year":"2008","unstructured":"Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008;15(2):261\u201371.","journal-title":"Dev Cell"},{"issue":"18","key":"484_CR217","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1161\/CIRCULATIONAHA.113.001720","volume":"128","author":"F Jansen","year":"2013","unstructured":"Jansen F, Yang X, Hoelscher M, Cattelan A, Schmitz T, Proebsting S, Wenzel D, Vosen S, Franklin BS, Fleischmann BK, et al. Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation. 2013;128(18):2026\u201338.","journal-title":"Circulation"},{"issue":"6","key":"484_CR218","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","volume":"107","author":"A Zampetaki","year":"2010","unstructured":"Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010;107(6):810\u20137.","journal-title":"Circ Res"},{"issue":"5","key":"484_CR219","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.109.215566","volume":"107","author":"S Fichtlscherer","year":"2010","unstructured":"Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller-Ardogan M, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107(5):677\u201384.","journal-title":"Circ Res"},{"key":"484_CR220","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12933-016-0367-8","volume":"15","author":"F Jansen","year":"2016","unstructured":"Jansen F, Wang H, Przybilla D, Franklin BS, Dolf A, Pfeifer P, Schmitz T, Flender A, Endl E, Nickenig G, et al. Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus. Cardiovasc Diabetol. 2016;15:49.","journal-title":"Cardiovasc Diabetol"},{"key":"484_CR221","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvw235","author":"S Rawal","year":"2016","unstructured":"Rawal S, Munasinghe P, Shindikar A, Paulin J, Cameron V, Manning P, Williams M, Jones GT, Bunton R, Galvin I, et al. Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy. Cardiovasc Res. 2016. doi: 10.1093\/cvr\/cvw235 .","journal-title":"Cardiovasc Res"},{"issue":"8","key":"484_CR222","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1249\/MSS.0b013e31824e8a36","volume":"44","author":"DA Silva","year":"2012","unstructured":"Silva DA, Jr ND, Fernandes T, Soci UP, Monteiro AW, Phillips MI, de Oliveira EM. Swimming training in rats increases cardiac MicroRNA-126 expression and angiogenesis. Med Sci Sports exerc. 2012;44(8):1453\u201362.","journal-title":"Med Sci Sports exerc"},{"issue":"8","key":"484_CR223","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1128\/MCB.01222-08","volume":"29","author":"S Ikeda","year":"2009","unstructured":"Ikeda S, He A, Kong SW, Lu J, Bejar R, Bodyak N, Lee KH, Ma Q, Kang PM, Golub TR, et al. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol. 2009;29(8):2193\u2013204.","journal-title":"Mol Cell Biol"},{"issue":"9","key":"484_CR224","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1172\/JCI36154","volume":"119","author":"TE Callis","year":"2009","unstructured":"Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, Chen JF, Deng Z, Gunn B, Shumate J, et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Investig. 2009;119(9):2772\u201386.","journal-title":"J Clin Investig"},{"issue":"5","key":"484_CR225","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cardfail.2010.01.002","volume":"16","author":"M Satoh","year":"2010","unstructured":"Satoh M, Minami Y, Takahashi Y, Tabuchi T, Nakamura M. Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy. J Cardiac Fail. 2010;16(5):404\u201310.","journal-title":"J Cardiac Fail"},{"issue":"7","key":"484_CR226","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.hrthm.2013.03.005","volume":"10","author":"TY Ling","year":"2013","unstructured":"Ling TY, Wang XL, Chai Q, Lau TW, Koestler CM, Park SJ, Daly RC, Greason KL, Jen J, Wu LQ, et al. Regulation of the SK3 channel by microRNA-499\u2014potential role in atrial fibrillation. Heart Rhythm. 2013;10(7):1001\u20139.","journal-title":"Heart Rhythm"},{"issue":"4","key":"484_CR227","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/ATVBAHA.109.197434","volume":"30","author":"JP Sluijter","year":"2010","unstructured":"Sluijter JP, van Mil A, van Vliet P, Metz CH, Liu J, Doevendans PA, Goumans MJ. MicroRNA-1 and-499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol. 2010;30(4):859\u201368.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8A","key":"484_CR228","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1582-4934.2008.00613.x","volume":"13","author":"C Solingen van","year":"2009","unstructured":"van Solingen C, Seghers L, Bijkerk R, Duijs JM, Roeten MK, van Oeveren-Rietdijk AM, Baelde HJ, Monge M, Vos JB, de Boer HC, et al. Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J Cell Mol Med. 2009;13(8A):1577\u201385.","journal-title":"J Cell Mol Med"},{"issue":"100","key":"484_CR229","doi-asserted-by":"crossref","first-page":"ra81","DOI":"10.1126\/scisignal.2000610","volume":"2","author":"A Zernecke","year":"2009","unstructured":"Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Koppel T, Jahantigh MN, Lutgens E, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009;2(100):ra81.","journal-title":"Sci Signal"},{"issue":"4","key":"484_CR230","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","volume":"13","author":"KC Vickers","year":"2011","unstructured":"Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13(4):423\u201333.","journal-title":"Nat Cell Biol"},{"issue":"9","key":"484_CR231","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.metabol.2015.05.013","volume":"64","author":"E Flowers","year":"2015","unstructured":"Flowers E, Aouizerat BE, Abbasi F, Lamendola C, Grove KM, Fukuoka Y, Reaven GM. Circulating microRNA-320a and microRNA-486 predict thiazolidinedione response: moving towards precision health for diabetes prevention. Metab Clin Exp. 2015;64(9):1051\u20139.","journal-title":"Metab Clin Exp"},{"issue":"2","key":"484_CR232","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/01902148.2016.1155245","volume":"42","author":"AA Ponomaryova","year":"2016","unstructured":"Ponomaryova AA, Morozkin ES, Rykova EY, Zaporozhchenko IA, Skvortsova TE, Dobrodeev AY, Zavyalov AA, Tuzikov SA, Vlassov VV, Cherdyntseva NV, et al. Dynamic changes in circulating miRNA levels in response to antitumor therapy of lung cancer. Exp Lung Res. 2016;42(2):95\u2013102.","journal-title":"Exp Lung Res"},{"issue":"11","key":"484_CR233","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.2337\/db09-0165","volume":"58","author":"A Granjon","year":"2009","unstructured":"Granjon A, Gustin MP, Rieusset J, Lefai E, Meugnier E, Guller I, Cerutti C, Paultre C, Disse E, Rabasa-Lhoret R, et al. The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c\/myocyte enhancer factor 2C pathway. Diabetes. 2009;58(11):2555\u201364.","journal-title":"Diabetes"},{"key":"484_CR234","unstructured":"miRagen therapeutics: pipeline. http:\/\/miragentherapeutics.com\/pipeline\/ . Accessed 29 April 2016."},{"issue":"18","key":"484_CR235","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","volume":"368","author":"HL Janssen","year":"2013","unstructured":"Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med. 2013;368(18):1685\u201394.","journal-title":"N Engl J Med"},{"issue":"5","key":"484_CR236","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1037\/0278-6133.21.5.452","volume":"21","author":"MG Perri","year":"2002","unstructured":"Perri MG, Anton SD, Durning PE, Ketterson TU, Sydeman SJ, Berlant NE, Kanasky WF Jr, Newton RL Jr, Limacher MC, Martin AD. Adherence to exercise prescriptions: effects of prescribing moderate versus higher levels of intensity and frequency. Health Psychol. 2002;21(5):452\u20138.","journal-title":"Health Psychol"},{"issue":"2","key":"484_CR237","doi-asserted-by":"crossref","first-page":"e000078","DOI":"10.1161\/JAHA.113.000078","volume":"2","author":"I Karakikes","year":"2013","unstructured":"Karakikes I, Chaanine AH, Kang S, Mukete BN, Jeong D, Zhang S, Hajjar RJ, Lebeche D. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J Am Heart Assoc. 2013;2(2):e000078.","journal-title":"J Am Heart Assoc"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-016-0484-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T18:53:53Z","timestamp":1692644033000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-016-0484-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,13]]},"references-count":237,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["484"],"URL":"https:\/\/doi.org\/10.1186\/s12933-016-0484-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,13]]},"article-number":"10"}}